Institutional investors hold a majority ownership of AMGN through the 83.55% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.7 Million shares of Amgen
JANUS CAPITAL MANAGEMENT LLC Bought 1.6 Million shares of Amgen
BLACKROCK FUND ADVISORS Bought 1.5 Million shares of Amgen